Where We Stand
Section: Pharmaceuticals
Policy: Cancer Drugs

Cancer Drugs

OMA will petition the AMA House of Delegates to seek implementation of an expedited approval process for drugs for fatal cancers, as well as work to increase the availability of promising cancer drugs for compassionate care.

Adopted at the interim House of Delegates, 2000.
Reaffirmed at the annual House of Delegates, 2011.

Return to the Where We Stand table of contents.